Capitol Health Reports Growth Amidst Increased Losses

Capitol Health Limited (AU:CAJ) has released an update.

Capitol Health Limited reported a 12% increase in revenue and a significant 22.6% and 25.0% rise in Operating EBITDA and Underlying NPAT, respectively, for the fiscal year ended June 30, 2024, compared to the previous year. Despite these strong operating results, the company experienced a 26.9% increase in losses, attributed largely to non-operating items such as transaction costs and asset impairments. No final dividend has been declared, and the dividend reinvestment plan remains suspended.

For further insights into AU:CAJ stock, check out TipRanks’ Stock Analysis page.